If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 6 of 6
Randomized COVID-19 Testing in Vulnerable Communities and Risk Tool Creation
Novel Methods For Estimating True Covid-19 Infection Rates And Progression Risks
Protocol No
IIT-MEURER-NIH-COVIDMKE
Categories
Expanded Access IND Protocol: Use of Tecovirimat (TPOXX) for Treatment of Human Orthopoxvirus Infections (CDC IND 116039, CDC IRB Protocol #6402)
TPOXX for Treatment of Human Orthopoxvirus Infections
Protocol No
INF-CDC-TPOXX-EA-IND-MONKEYPOX
Categories
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients With Treatment-refractory Mycobacterium Avium Complex Lung
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Protocol No
INF-AN2-EBO-301-MAC
Categories
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Safety, Tolerability, and Efficacy of Intravenous AP-SA02 as an Adjunct to Best Available Antibiotic Therapy for the Treatment of Adults With Bacteremia Due t
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia (diSArm)
Protocol No
INF-ARMATA-DISARM
Categories
NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults
Understanding the Long-term Impact of COVID-19 in Adults
Protocol No
OBG-NHLBI-RECOVER
Categories
Ansun BioPharma Phase 3 Lower Respiratory Tract PIV Infection in Immunocompromised Subjects DAS181-3-01 OXA65631
Lower Respiratory Tract PIV Infection in Immunocompromised Subjects
Protocol No
PULM-ANSUN-BIOPHARMA-FQ
Categories